Top

Published in:

Open Access 01-12-2018 | Case Report

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report

Authors: Ricardo Garcia Pastorello, Felipe D’Almeida Costa, Cynthia A. B. T. Osório, Fabiana B. A. Makdissi, Stephania Martins Bezerra, Marina de Brot, Antonio Hugo J. F. M. Campos, Fernando Augusto Soares, José Vassallo

Published in: Diagnostic Pathology | Issue 1/2018

Abstract

Background

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare malignancy, recently recognized as a provisional entity by the World Health Organization. Although increasing data have been published on this entity in recent years, a great number of patients and health professionals remain unaware of this diagnosis.

Case presentation

We herein report the case of a 56-year-old female with Li-FRAUMENI syndrome who presented with late right-sided recurrent breast swelling after prophylactic adenomastectomy with implant reconstruction. Imaging scans revealed an heterogeneous mass adjacent to the implant fibrous capsule. A biopsy of the lesion rendered the diagnosis of a BIA-ALCL.

Conclusions

This case presents similarities with previous reports, but also some particularities, which should be stressed in order to make the diagnosis the earliest possible. The most distinct feature is that this is the second report of BIA-ALCL arising in the setting of Li-FRAUMENI syndrome.

Kaartinen I, Sunela K, Alanko J, Hukkinen K, Karjalainen-Lindsberg M-L, Svarvar C. Breast implant-associated anaplastic large cell lymphoma – From diagnosis to treatment. Eur J Surg Oncol [Internet]. 2017 Aug [cited 2017 Oct 3];43(8):1385–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28625797.

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood [Internet]. 2016 [cited 2017 Jul 15];127(20). Available from: http://www.bloodjournal.org/content/127/20/2375?sso-checked=true

Keech JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg [Internet]. 1997 [cited 2017 Oct 3];100(2):554–555. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9252643.

Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MW. U.S. Epidemiology of Breast Implant–Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg [Internet]. 2017 [cited 2017 Oct 3];139(5):1042–1050. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28157769.

Johnson L, O’Donoghue JM, McLean N, Turton P, Khan AA, Turner SD, Lennard A, Collis N, Butterworth M, Gui G, Bristol J, Hurren J, Smith S, Grover K, Spyrou G, Krupa K, Azmy IA, Young IE, Staiano JJ, Khalil H, MacNeill FA. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol [Internet]. 2017 [cited 2017 Oct 3];43(8):1393–1401. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28596034.

Gualco G, Chioato L, Harrington WJ, Weiss LM, Bacchi CE, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol AIMM [Internet]. 2009 [cited 2017 Oct 3];17(4):301–306. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19318917.

Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, Amin MB, Haideri N, Bhagat G, Brooks GS, Shifrin DA, O’Malley DP, Cheah CY, Bacchi CE, Gualco G, Li S, Keech JA, Hochberg EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning JT, Xu-Monette ZY, Miranda AR, Fox P, Bassett RL, Castillo JJ, Beltran BE, de Boer JP, Chakhachiro Z, Ye D, Clark D, Young KH, Medeiros LJ. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol [Internet]. 2014 Jan 10 [cited 2017 Oct 3];32(2):114–120. Available from: http://ascopubs.org/doi/10.1200/JCO.2013.52.7911

Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, Fanale M, Haideri N, Mustafa E, Larrinaga J, Reisman NR, Jaso J, You MJ, Young KH, Medeiros LJ, Yang W. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat [Internet]. 2014 [cited 2017 Oct 3];147(1):1–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25073777.

Glenn MJ, Harris NL. T-cell Lymphomas. Natl Compr Cancer Netw. 2017;(T-cell Lymphomas. Version 2.2017).

10.

Chai SM, Kavangh S, Ooi SS, Sterrett GF, Cull G, Plunkett M, Spagnolo D, Amanuel B, Joske D, Leslie C, Barham T, Frost F. Anaplastic large-cell lymphoma associated with breast implants: A unique entity within the spectrum of peri-implant effusions. Diagn Cytopathol [Internet]. 2014 [cited 2017 Oct 3];42(11):929–938. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24687769.

11.

Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, Traverse-Glehen A, Rousset T, Quintin-Roue I, Petrella T, Emile JF, Amara N, Rochaix P, Chenard-Neu MP, Tasei AM, Menet E, Chomarat H, Costes V, Andrac-Meyer L, Michiels JF, Chassagne-Clement C, de Leval L, Brousset P, Delsol G, Lamant L. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27(2):306–14.CrossRefPubMed

12.

Gazzola A, Mannu C, Rossi M, Laginestra MA, Sapienza MR, Fuligni F, Etebari M, Melle F, Sabattini E, Agostinelli C, Bacci F, Sagramoso Sacchetti CA, Pileri SA, Piccaluga PP. The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies. Ther Adv Hematol. 2014;5(2):35–47.CrossRefPubMedPubMedCentral

13.

Ye X, Shokrollahi K, Rozen WM, Conyers R, Wright P, Kenner L, Turner SD, Whitaker IS. Anaplastic large cell lymphoma (ALCL) and breast implants: Breaking down the evidence. Mutat Res - Rev Mutat Res [Internet]. 2014;762:123–132. Available from: https://doi.org/10.1016/j.mrrev.2014.08.002

14.

Fletcher CL, Orchard GE, Hubbard V, Whittaker SJ, Edelson RL, Russell-Jones R. CD30(+) cutaneous lymphoma in association with atopic eczema. Arch Dermatol [internet]. 2004;140(4):449–54. Available from. http://www.ncbi.nlm.nih.gov/pubmed/15096373

15.

Royds JA, Iacopetta B. p53 and disease: when the guardian angel fails. Cell Death Differ. 2006;13(6):1017–26.CrossRefPubMed

16.

Barnes DM, Fisher CJ, Path MRC, Rasbridge SA, Path MRC, Macgeoch C, Lane DP. The p53 protein detected by immunohistochemical staining is not always mutant biomarker for breast cancer chemoprevention : antimalignin antibody. :211113.

17.

Cesarman E, Lnghirami G, Chadburn A, Knowles DM. High Levels of p53 Protein Expression Do Not Correlate with p53 Gene Mutations in Anaplastic Large Cell Lymphoma. Am J Pathol [Internet]. 1993 [cited 2017 Dec 23];143(3). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887225/pdf/amjpathol00069-0203.pdf

18.

Rassidakis GZ, Thomaides A, Wang S, Jiang Y, Fourtouna A, Lai R, Medeiros LJ. P53 gene mutations are uncommon but P53 is commonly expressed in anaplastic large-cell lymphoma. Leukemia. 2005;19(9):1663–9.CrossRefPubMed

19.

Lee Y-S, Filie A, Arthur D, Fojo AT, Jaffe ES. Breast implant-associated anaplastic large cell lymphoma in a patient with Li-FRAUMENI syndrome. Histopathology [Internet]. 2015 [cited 2017 Oct 3];67(6):925–927. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25974645.

Title: Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report
Authors: Ricardo Garcia Pastorello
Felipe D’Almeida Costa
Cynthia A. B. T. Osório
Fabiana B. A. Makdissi
Stephania Martins Bezerra
Marina de Brot
Antonio Hugo J. F. M. Campos
Fernando Augusto Soares
José Vassallo
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Diagnostic Pathology / Issue 1/2018
Electronic ISSN: 1746-1596
DOI: https://doi.org/10.1186/s13000-018-0688-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report

Abstract

Background

Case presentation

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases

Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array

Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report

Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers